Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
D000588:Amines / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced*; D013329:Structure-Activity Relationship
D000588:Amines; D000970:Antineoplastic Agents; D004317:Doxorubicin; D003630:Daunorubicin